Cargando…
Pulmonary Hypertension Associated with Idiopathic Pulmonary Fibrosis: Current and Future Perspectives
Pulmonary hypertension (PH) is commonly present in patients with chronic lung diseases such as Chronic Obstructive Pulmonary Disease (COPD) or Idiopathic Pulmonary Fibrosis (IPF) where it is classified as Group III PH by the World Health Organization (WHO). PH has been identified to be present in as...
Autores principales: | Collum, Scott D., Amione-Guerra, Javier, Cruz-Solbes, Ana S., DiFrancesco, Amara, Hernandez, Adriana M., Hanmandlu, Ankit, Youker, Keith, Guha, Ashrith, Karmouty-Quintana, Harry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5327768/ https://www.ncbi.nlm.nih.gov/pubmed/28286407 http://dx.doi.org/10.1155/2017/1430350 |
Ejemplares similares
-
Mechanisms of Pulmonary Hypertension in Acute Respiratory Distress Syndrome (ARDS)
por: Revercomb, Lucy, et al.
Publicado: (2021) -
Adenosine and hyaluronan promote lung fibrosis and pulmonary hypertension in combined pulmonary fibrosis and emphysema
por: Collum, Scott D., et al.
Publicado: (2019) -
Nanotherapeutics for Treatment of Pulmonary Arterial Hypertension
por: Segura-Ibarra, Victor, et al.
Publicado: (2018) -
Switching-Off Adora2b in Vascular Smooth Muscle Cells Halts the Development of Pulmonary Hypertension
por: Mertens, Tinne C. J., et al.
Publicado: (2018) -
Evaluation, Diagnosis, and Classification of Pulmonary
Hypertension
por: Sarah, Beshay, et al.
Publicado: (2021)